Pio Conti Scienziato

Il Prof. Pio Conti, immunologo, è tra gli autori di una ricerca dal titolo “SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors” pubblicata sull’importante giornale: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE OF THE UNITED STATE OF AMERICA (PNAS), organo ufficiale dell’Accademia delle Scienze degli USA e ad altissima diffusione internazionale.

La pubblicazione e’ stata realizzata in collaborazione con la TUFTS University di Boston, dove il Prof. Pio Conti lavora e insegna da alcuni decenni con il ruolo di “Affiliated Professor“.

 

Academic Appointments

1972-76 Internship: Research-Laboratory & Clinical Analysis at the Civil Hospital of Teramo, Italy.

1975-76 Research Associate, Department of General Pathology, Medical School, L’Aquila University, Italy

1976-77 Assistant in Charge of General Pathology at L’Aquila Medical School, Italy

1977 Attended: Rheumatology and Experimental Pathology, Dept. of St. Bartholomew’s Hospital Medical College of London, England (directed by Professor D.A. Willoughby)

1977-82 Assistant Professor of General Pathology, L’Aquila Medical School, Italy

  1. Attended: Georgetown University School of Medicine, Dept. of Physiology and Biophysics of Washington, D.C., U.S.A. (directed by Dr. Peter Ramwell)

  2. -83 Attended the Ph.D. Program: Georgetown University School of Medicine, Immunology Center, Washington DC, USA (directed by Dr. Joseph A. Bellanti).

1982-99 Associate Professor of Immunology and General Pathology, University of Chieti, Italy

1982-3 Honorary member, Immunology Center (directed by Dr. Joseph Bellanti), Georgetown University, Washington, D.C., U.S.A.

1984-2010 Visiting Professor, TUFTS University, Medical School, Boston, Ma., USA

1988- Editor-in-Chief and founder of “International Journal of Immunopathology and Pharmacology” (now SAGE Ed.)

1989 President of “International Congress on AIDS, University of Chieti, Italy

1999-14 Professor of Immunology and General Pathology, University of Chieti, Italy

2000-11 Visiting Professor and Teacher at Aristotelian University of Thessaloniki, Greece

2002- Editor-in-Chief and founder of “European Journal of Inflammation” (now SAGE Ed.)

2004 Honorary Doctor of Medicine, IMAB, Medical School, Varna, Bulgaria.

2007- Editor-in-Chief of “Journal Biological Regulators & Homeostatic Agents” (BIOLIFE)

2009 AWARD for completion of research collaboration from 1984 to 2009. TUFTS University Medical School, Boston, USA.

2010- Affiliated Professor, Department of Pharmacology, Medical School, TUFTS University,

Boston, Ma, USA.

2015 Professor of Immunology, Post-graduate Medical School, University of Chieti, Italy.

2021 Italian Medicine AWARD (Pescara, Italy)

 

Dr. Pio Conti is a Professor of Immunology with extensive teaching experience. He has great experimental experience (over 40 years) in the lab with a wide spectrum of immunological diseases and has active experimental research interests in the inflammatory and immunology fields. His research interests also include innate and adaptive immunity, immunological disorders, mast cell biology, cytokine/chemokine immunoregulation, NK cells and tumor immunology, asthma, and allergy.

 

He has collaborated with eminent scientists from many countries:

  1. Willoghby D.A.: leader on chemical mediators of inflammation

  1. Ramwell P.W: leader on eicosanoids GEORGETOWN UNIVERSITY, Washington DC, USA.

  2. -3 Bellanti J.A: leader immunologist, author of the well-known text book of Immunology, GEORGETOWN UNIVERSITY, Washington DC, USA.

1982-3 Terry W. Williams: participated in the discovery of lymphotoxin.

1984-5 Charles A. Dinarello: purified and cloned IL-1 for the first time and discovered IL-18, IL-33, IL-37, IL-38, IL-1RA and some other cytokines.

    1. James W. Mier: discoverer of IL-2 (with Dr Robert Gallo, NIH, Bethesda, USA).

1985-6 Serhan C.N.: discoverer of lipoxins, HARVARD Medical School, Boston, USA (collaborator of Dr. Bengt I. Samuelsson Nobel Prize winner),.

  1. Oppenheimer JJ: discoverer of chemokines (NIH, Bethesda, USA).

1986-2022 Theoharides T.C.: international leader on mast cells, TUFTS University, Boston, USA

2010-2022 Leeman S.E: discoverer of substance P (member of the American Academy of Sciences, (Nobel Prize candidate), Boston University, USA.

 

Relevant Research Projects

Role of RANTES and MCP-1 in Acute Inflammatory Response. PI:Pio Conti, Professor, Ministry of Scientific Research and Technology, Rome, Italy. Duration:3/97-3/01. Studying the mediation of RANTES and MCP-1 injected in tissue and the recruitment and activation of mast cells.

Expression in Secretion of RANTES and MCP-1 in Granulomatosis Calcified Tissue. PI:Pio Conti, Ph.D. Ministry of Scientific Research and Technology University of Chieti Medical School, Chieti, Italy. Duration:3/97-3/01. Studying the gene expression and translation of RANTES and MCP-1 after induction of granulo inflammation calcified tissue by potassium permanganate (KMn04).

Interrelationship between COX2 and RANTES and MCP-1. PI:Pio Conti, Ph.D. Merck Sharp & Dohme, Italy. Studying the influence of RANTES and MCP-1 in using transcription and translation of COX2. Effect of a specific anti-COX2.

Role of IL-6, IL-10, IL-10 and IL-18 in inflammation. PI: Pio Conti, Ph.D. Ministry of Scientific Research and Technology, Rome, Italy. Studying the effect of IL-6, IL-10, IL-16 and IL-18 in mast cell activation

Role of MCP-1 and RANTES in parasite infection . PI: Pio Conti, Ph.D. Ministry of Scientific Research and Technology, Rome, Italy. Studying chemokine transcription and translation in infected parasite tissue.

Pro-Inflammatory IL-1 Family Members and IL-37. PI: Pio Conti, Ph.D. TUFTS University, Molecular Immunopharmacology and Drug Discovery Laboratory, Boston Ma, USA. Studying IL-33 and mast cells, and the inhibitory effect of IL-37 in inflammation.

Role of Cytokine in COVID-19. PI: Pio Conti, Ph.D. TUFTS University, Molecular Immunopharmacology and Drug Discovery Laboratory, Boston Ma, USA and University of Chieti-Pescara, Italy. Studying cytokines in COVID-19 (In 2020, one publication on this subject has received 1,471 citations to date).

 

Textbooks:

  • Conti P, Cifone MG, Alesse E. Lezioni su prostaglandine e leucotrieni. Libreria Universitaria Chieti, 1-206, 1985.

  • Conti P, Alesse E, Gigante GE, Cifone MG, Reale M, Fieschi C, Angeletti PU. Effetti di campi magnetici ELF sulla risposta di linfociti umani normali alla stimolazione mitogenica con lectine. Nuove frontiere in oncologia. L’interazione magnetobiologica. Ed. Bistolfi F e Marinari UM. 128-131, 1985.

  • Conti P. Gigante GE, Cifone MG, Alesse E, Fieschi C, Angeletti PU. Effects induced in vitro by ELF on blastogenesis of human lymphocytes and on thromboxane B2 release by ionophorestimulated neutrophils. Biological effects and dosimetry of static and ELF electromagnetic fields. Ed. Grandolfo M., Michaelson SM and Rindi A, Plenum Publishing Corporation, 335-338, 1985

  • Conti P, Mier JW, Boidi E, Cifone MG, Alesse E, Reale M, Dinarello CA. Effect of human peripheral blood mononuclear cells on target myeloid and lymphoid cell lines after pretreatment with indomethacin alone and in combination with IFNα or IFNγ. Advances in inflammation research. Raven Press N.Y., 10, 296-299, 1986

  • Conti P, Alesse E, Gigante GE, Cifone MG, Reale M, Fieschi C, Angeletti PU. Effetti di cxampi magnetici pulsati a bassa frequenza ELF-EMF sulla mitogenesi di linfociti umani normali. Campi magnetici in medicina. Ed. Minerva Medica, 335-338, 1986

  • Pio Conti, Citochine e Immunologia, Biomedical Research Press (5 editions: 1990, 1992, 1995, 1999, 2000).

 

 

Selected Publications (from a total of over 400).


Theoharides TC, Conti P. Mast cells to dendritic cells: Let IL-13 shut your IL-12 down.

J Allergy Clin Immunol. 2021 Jun;147(6):2073-2074.

– Tsilioni I, Pantazopoulos H, Conti P, Leeman SE, Theoharides TC.IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16475-16480.

Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL1 and IL-6) and lung inflammation by Coronavirus19 (COVI-19 or SARSCoV2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 March-April,;34(2):327-331 (1,471 citations).

-Tsilioni I, Patel AB, Pantazopoulos H, Berretta S, Conti P, Leeman SE, Theoharides TC. IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin. Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21659-21665. 

-Taracanova A, Tsilioni I, Conti P, Norwitz ER, Leeman SE, Theoharides TC.Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9381-E9390. 

– Theoharides TC, Taracanova A, Tsilioni I, Conti P, Leeman SE. Reply to Fattori et al.: Action of SP and IL-33 on mast cells. Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201716233.

– Giacoppo S, Thangavelu SR, Diomede F, Bramanti P, Conti P, Trubiani O, Mazzon E. Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. FASEB J. 2017 Dec;31(12):5592-5608.

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37. Eur J Pharmacol. 2017 Sep 29;818:294-299. doi: 10.1016/j.ejphar.2017.09.044.

-Taracanova A, Alevizos M, Karagkouni A, Weng Z, Norwitz E, Conti P, Leeman SE, Theoharides TC. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. Proc Natl Acad Sci U S A. 2017;114(20):E4002-E4009. doi: 10.1073/pnas.1524845114.

– Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A. 2010;107(9):4448-53.

Conti P, Carinci F, Lessiani G, Spinas E, Kritas SK, Ronconi G, Caraffa A, Theoharides TC. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells. Immunol Res. 2017 Jul 26. doi: 10.1007/s12026-017-8938-7.

-Pandolfi F, Franza L, Mandolini C, Conti P. Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. Clin Ther. 2017 May;39(5):884-893. doi: 10.1016/j.clinthera.2017.03.012.

– Conti P, Shaik-Dasthagirisaheb YB. Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders. Neurotox Res. 2015 Jun 3, Aug;28(2):147-53. doi: 10.1007/s12640-015-9533-0.

– Petra AI, Panagiotidou S, Stewart JM, Conti P, Theoharides TC. Spectrum of mast cell activation disorders. Expert Rev Clin Immunol. 2014 Jun;10(6):729-39.

– Sismanopoulos N, Delivanis DA, Mavrommati D, Hatziagelaki E, Conti P, Theoharides TC. Do mast cells link obesity and asthma? Allergy. 2013 Jan;68(1):8-15. doi: 10.1111/all.12043. Epub 2012 Oct 16. Review.

– De Berardis D, Serroni N, Campanella D, Olivieri L, Moschetta FS, Conti CM, Conti P, Di Giannantonio M. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. J Clin Psychopharmacol. 2012 Apr;32(2):289-90.

– Theoharides TC, Zhang B, Conti P. Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. J Clin Psychopharmacol. 2011 Dec;31(6):685-7.

– Kempuraj D, Conti P, Vasiadi M, Alysandratos KD, Tagen M, Kalogeromitros D, Kourelis T, Gregoriou S, Makris M, Stavrianeas NG, Theoharides TC. IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol. 2010 Nov-Dec;20(6):865-7.

Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007 Jun;217:65-78. Review. (I.F. 10.758)

– Theoharides TC, Weinkauf C. and Conti P. Brain cytokines and neuropsychiatric disorders. J Clinical Psychopharmacol 2004; 24 (6) 577-581 (I.F. 4.432)

– Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci. 2004 Nov;25(11):563-568 (I.F. 13.965)

Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, Felaco M, Boucher W, Theoharides TC. IL-10, an inflammatory/inhibitory cytokine, but not always, Immunol Lett.2003, 86:123-129.

Conti P, Kempuraj D, Di Gioacchino M, Boucher W, Letourneau R, Kandere K, Barbacane RC, Reale M, Felaco M, Frydas S, Theoharides TC. Interleukin-6 and mast cells. Allergy Asthma Proc. 2002 23:331-5.

Frydas S, Papaioannou N, Reale M, Barbacane RC, Conti P. MCP-1 and MIP-2 response in Trichinella spiralis infected mice treated with 4-deoxypyridoxine (4-DPD). Immunol Lett. 2002 83:31-7.

Conti P. The anti-inflammatory actions of azelastine. Allergy Asthma Proc. 2002 23:153-5.

Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Reale M, Barbacane RC, Castellani ML, Mortari U, Boucher W, Letourneau R, Theoharides TC. Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc. 2002 23:103-8.

Conti P, Frydas S, Reale M, Barbacane RC, Di GM, Felaco M, Trakatellis A. Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis. Mol Cell Biochem. 2002 Jan;229(1-2):129-37.

Reale M, Intorno R, Tenaglia R, Feliciani C, Barbacane RC, Santoni A, Conti P. Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
Cancer Immunol Immunother. 2002 Apr;51(2):91-8.

Iarlori C, Reale M, De Luca G, Di Iorio A, Feliciani C, Tulli A, Conti P, Gambi D, Lugaresi A. Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2002 Feb;123(1-2):170-9. (I.F. 3.054).

Conti P, Reale M, Barbacane RC, Castellani ML, Orso C. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol Lett. 2002 Feb 1;80(2):105-11.

Conti P, DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 2001 May-Jun;22(3):133-7.

Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA, Di Napoli P, Di Giulio C, Barbacane R, Conti P. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Ann Clin Lab Sci. 2001 Apr;31(2):179-86.

Conti P, Barbacane RC, Feliciani C, Reale M. Expression and secretion of RANTES by human peripheral blood CD4+ cells are dependent on the presence of monocytes. Ann Clin Lab Sci. 2001 Jan;31(1):75-84.

Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D’Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. ArteriosclerThromb Vasc Biol. 2001 Mar;21(3):327-34.

Barsotti A, Di Napoli P, Taccardi AA, Spina R, Stuppia L, Palka G, Barbacane RC, De Caterina R, Conti P. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis. 2001 Mar;155(1):53-9. (I.F. 3.603).

Reale M, Barbacane RC, DiGioacchino M, Felaco M, Croce A, Ferro FM, Lotti TM, Conti P. Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. Immunol Lett. 2001 Feb 1;76(1):7-14.

Felaco M, Di Maio FD, De Fazio P, D’Arcangelo C, De Lutiis MA, Varvara G, Grilli A, Barbacane RC, Reale M, Conti P. Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp. Life Sci. 2000 Dec 8;68(3):297-306.

Felaco M, Grilli A, Gorbunov N, Di Napoli P, De Lutiis MA, Di Giulio C, Taccardi AA, Barsotti A, Barbacane RC, Reale M, Conti P. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. Biochim Biophys Acta. 2000 Dec 15;1524(2-3):203-11.

Boscolo P, Di Gioacchino M, Sabbioni E, Di Giacomo F, Reale M, Volpe AR, Di Sciascio MB, Conti P, Giuliano G. Lymphocyte subpopulations, cytokines and trace elements in asymptomatic atopic women exposed to an urban environment. Life Sci. 2000;67(10):1119-26. (I.F. 1.944)

Iarlori C, Reale M, Lugaresi A, De Luca G, Bonanni L, Di Iorio A, Feliciani C, Conti P, Gambi D. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b. J Neuroimmunol. 2000 Jul 10;107(1):100-7. (I.F. 3.054).

Di Napoli P, Di Muzio M, Maggi A, Taccardi AA, Conti P, Barsotti A. Simvastatin reduces postischemic coronary dysfunction: ultrastructural and functional findings after acute administration. Microvasc Res. 2000 Jan;59(1):181-5.

Conti P, Reale M, Grilli A, Barbacane RC, Di Luzio S, Di Gioacchino M, De Lutiis MA, Felaco M. Effect of electromagnetic fields on several CD markers and transcription and expression of CD4. Immunobiology. 1999 Sep;201(1):36-48.

Frydas S, Papaioanou N, Vlemmas I, Theodoridis I, Anogiannakis G, Vacalis D, Trakatellis A, Barbacane RC, Reale M, Conti P. Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice. Mol Cell Biochem. 1999 Jul;197(1-2):79-85.

Conti P, Barbacane RC, Reale M. Chemokines in inflammatory states. Allergy Asthma Proc. 1999 Jul-Aug;20(4):205-8. (I.F. 0.861)

Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites. J Pathol. 1997 Nov;183(3):352-8. (I.F. 4.933)

Conti P, Reale M, Feliciani C, Frydas S, Trakatellis M, Placido FC, Cataldo I, Di Gioacchino M, Barbacane RC. Augmentation of monocyte chemotactic protein-1 and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo. Immunology. 1997 Oct;92(2):300-6.

Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. Int Immunol. 1997 Oct;9(10):1563-70. (I.F. 3.690)

Porreca E, Di Febbo C, Reale M, Castellani ML, Baccante G, Barbacane R, Conti P, Cuccurullo F, Poggi A. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res. 1997 Jan-Feb;34(1):58-65.

Porreca E, Reale M, Di Febbo C, Di Gioacchino M, Barbacane RC, Castellani ML, Baccante G, Conti P, Cuccurullo F. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. Immunology. 1996 Nov;89(3):424-9. (I.F. 2.853)

Porreca E, Di Febbo C, Di Sciullo A, Angelucci D, Nasuti M, Vitullo P, Reale M, Conti P, Cuccurullo F, Poggi A. Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia. Thromb Haemost. 1996 Jul;76(1):99-104. (I.F. 4.950)

Conti P, Reale M, Barbacane RC, Letourneau R, Theoharides TC. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J. 1998 Dec;12(15):1693-700.

Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood. 1997 Jun 1;89(11):4120-7.

 

CONFERENCES

1984 Invited speaker, Division of Experimental Medicine, Tufts University Medical School, Boston, MA

1985 Invited speaker, Division of Experimental Medicine, Tufts University Medical School, Boston, MA

1986 Invited speaker in two international congresses: 1. Seventh European Rheumatology Research Workshop, March 6-8, 1987, Glasgow, Scotland; 2.

1987 Invited speaker, Martin Luther University of Halle, Section of Pharmacology, Germany

1989 Invited speaker, “Freie Universitat,”Dept of Biochemistry and Pharmacology, Berlin, Germany

1992 Invited speaker, University of Brest Medical School, France

1992 Invited speaker, Catholic University, Institute of Clinical Medicine and Medical Therapy, Rome, Italy

1992 Invited speaker, Dept. of Infection and Parasitic Diseases, Aristotelien University, Thessaloniki, Greece

1992 Invited speaker, Dept. of General Pathology, University of Moderna, Italy

1993 Invited speaker, Dept. of Biochemistry, Medical School, Aristotelien University, Thessaloniki, Greece

1993 Chairman, Workshop on HIV Infections, Italian Society of Hygiene and Preventive Medicine in Public Health, Naples, 2-12, 1993, Italy

1994 Chairman, International Workshop on flow cytometry, Cotugno Hospital, Naples 5-2, 1994, Italy

2000 Chairman, “IMAB Congress” 25-27, May, 2000, Varna, Bulgaria

2002 International Congress: Immune and Neurological Effects of Work and Environment, Taiyuan Shanxi, China.

 

Da Visitare anche:

https://www.researchgate.net/profile/Pio_Conti

https://unich-it.academia.edu/PioConti

https://loop.frontiersin.org/people/233398/overview

https://scholar.google.co.uk/citations?user=gzoVZ9MAAAAJ&hl=it